BCL6 and diffuse large B-cell lymphoma: In addition, TOX was expressed by 4/10 BCL6+ PCDLBCL,LT and 2/2 BCL6+ secondary cutaneous DLBCL, but not or only weakly in a minority of the neoplastic B-cells in 3/3 BCL6− PCDLBCL,LT.